TMCnet News
Research and Markets: MediPoint: Aortic Stent Grafts - EU Analysis and Market Forecasts 2013-2020DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/r9pvcv/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - EU Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. TheEU market continues to be the second biggest market for aortic stent grafts at 23% of the global scene. Of this, Germany remains the leader as they are the pioneers of cardiovascular innovations and have a strong local manufacturing base. Similar to the US, the leading companies in the EU aortic stent grafts market are Medtronic, Cook Medical, and Gore Medical, with emerging players such as Endologix. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/r9pvcv/medipoint_aortic
|